Summary
Monoamine oxidase-B (MAO-B) has been determined to be the enzyme responsible for the conversion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into its toxic metabolite 1-methyl-4-phenylpyridine ion (MPP+). Since this enzyme has been localized primarily in astrocytes and serotonergic neurons, it would appear that MPP+ is being produced outside the dopaminergic neurons. To investigate this possibility, the administration of MPTP was preceded by systemically administered fluoxetine. In keeping with its demonstrated ability to inhibit uptake into serotonergic neurons and serotonin uptake into astrocytes, fluoxetine pretreatment resulted in a significant attenuation of MPTP-induced depletions of striatal dopamine and serotonin concentration. These results support the extra-dopaminergic production of MPP+.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brooks WJ, Jarvis MF, Wagner GC (1986) Mediation of MPTP-induced dopaminergic neurotoxicity by serotonergic neurons. 16th annual meeting Society for Neuroscience, Washington, D.C.
Burns RS, Chiueh CC, Markey SP, Ebert HM, Jacobowitz DM, Kopin IJ (1983) A primate model of parkin-sonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6, -tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546–4550
Chiba K, Trevor AJ, Castagnoli N (1984) Metabolism of the neurotoxic tertiary amine MPTP by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574–578
Davis GC, Williams AC, Markey SP, Ebert MH, Reichert CM, Kopin, IJ (1979) Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249–254
Fuller RW, Perry KW, Molloy BB (1975) Effect of 3-(p-trifluromethylphenoxy) methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J Pharmacol Exp Ther 193: 796–803
Heikkila RE, Hess A, Duvoisin RC (1984 a) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 244: 1451–1453
Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC (1984 b) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311: 467–469
Jarvis MF, Wagner GC (1985) Age dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuropharmacology 24: 581–582
Javitch JA, Snyder SH 61984) Uptake of MPP+ by dopamine neurons explains selectivity of parkinsonian inducing toxin, MPTP. Eur J Pharmacol 106: 455–456
Kimelberg HK (1986) Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes. Biochem Pharmacol 35: 2273–2281
Kimelberg HK, Katz DM (1985) High-affinity uptake of serotonin into immunocytochemically identified astrocytes. Science 228: 889–891
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980
Langston JW, Forno LS, Rebert CS, Irwin I (1984 a) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292: 390–394
Langston JW, Irwin I, Langston EB, Forno LS (1984 b) Pargyline prevents MPTP induced parkinsonism in primates. Science 225: 1480–1482
Levitt P, Pintar JE, Breakfield XO (1082) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA 79: 6385–6389
Mayer RA, Jarvis MF, Wagner GC (1985) Cocaine blocks the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Res Commun Chem Pathol Pharmacol 149: 145–148
Ricaurte GA, Langston JA, Delanney LE, Irwin I, Brooks JD (1985) Dopamine uptake blockers protect againt the dopamine depleting effects of 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine (MPTP) in the mouse striatum. Neurosci Lett 59: 259–264
Shen RS, Abell CW, Gessner W, Brassi A (1985) Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. FEBS Lett 189: 225–230
Sundstrom E, Jonsson G (1986) Differential time course protection by monoamine oxidase inhibition an uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice. Eur J Pharmacol 122: 275–278
Wagner GC, Gardner J, Tsigas DJ, Masters DB (1984) Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion. Drug Alcohol Depend 13: 225–234
Westlund KN, Denney LM, Kochersperger RM, Abell CW (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230: 181–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brooks, W.J., Jarvis, M.F. & Wagner, G.C. Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker. J. Neural Transmission 71, 85–90 (1988). https://doi.org/10.1007/BF01245250
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245250